gci

Current Issue cover

Oliveda Achieves 56% Growth 2019, Plans for More Than 100% 2020

Contact Author
Close
Fill out my online form.

Oliveda International, Inc. has announced it achieved 56% growth in 2019 and is planning for additional growth of more than 100% in 2020.

Oliveda International, Inc. has announced it achieved 56% growth in 2019 and is planning for more than 100% growth in 2020.

After being upgraded to “Pink Current Information” on the OTC Markets Group website in March 2019, the company obtained FDA registration approval for all Oliveda products in April and had its U.S. launch online in May.

In 2019, the company launched numerous new products, including its Beauty Molecule, which was met with immediate success, entering the Oliveda’s top ten best-selling products within a few weeks.

New companies and brands were developed in 2020, such as LA Dope, Olive Tree People and Oliveda America, as well as new technologies and sales contracts for more than 20,000 of its own mountain olive trees.

Oliveda also obtained retail approval for the China market and launched a globally unique CBD technology that can be used immediately worldwide without further approvals, thus creating new sales channels.

“In addition to these many developments in 2019, we ended the year with growth of 56%,” Oliveda founder and CEO Thomas Lommel said. “Based on all these preparations, we plan to achieve growth of over 100% in 2020 and target a listing on the Nasdaq in 2021.”